Autoimmunity markers in subjects with diabetes

Journal Title: Journal of Pre-Clinical and Clinical Research - Year 2016, Vol 10, Issue 1

Abstract

[b]Introduction.[/b] Diabetes is a growing social and epidemiological problem. Accordingly, the incidence of complications associated with diabetes can cause a persistent high percentage of diseases of the cardiovascular system, kidney and nervous systems, and impaired vision. [b]Objective.[/b] The aim of the study was to evaluate the incidence of immunological markers in patients with type 1 diabetes and those with type 2 diabetes: the anti-GAD, ANA, AMA, ASMA, APCA and LKM, compared to healthy people. Another objective of the study was to evaluate the correlation between their presence and the degree of metabolic control in both groups. [b]Materials and methods[/b]. The study comprised 100 subjects aged 25–75 years with a body mass index (BMI) between 20–30 kg / m2, hospitalized in the Department of Internal Diseases, Diabetology and Endocrinology, at the Medical University of Warsaw, with previously diagnosed diabetes who were assigned to one of 2 groups (50 subjects with type 1 diabetes and 50 subjects with type 2 diabetes). The control group consisted of 21 healthy individuals without the diagnosis of diabetes and a prediabetic state. All the study participants had the examined antibodies determined along with the panel of biochemical tests and neurological examination for diabetic neuropathy and fundus examination. [b]Results. [/b]Anti-GAD antibodies were present in both groups of patients. Their presence was found in 30% of people with type 1 diabetes and in 16% of people with diabetes type 2. The presence of ANA antibodies was found in 24% of people with type 1 diabetes and 22% of people with type 2 diabetes. There was no correlation between the presence of ANA antibodies ANA and duration of diabetes. In the group of patients with type 1 diabetes, there was a correlation between the presence of ANA and the incidence of diabetic polyneuropathy. ASMA and APCA antibodies occurred with equal frequency in both studied groups (4% vs. 10%). There were no antibodies of AMA or anti-LKM in any of the patients. [b]Conclusions[/b]. Marking of ANA antibodies in patients with type 1 diabetes may be a marker used to isolate a group of patients at risk of developing diabetic neuropathy. The presence of anti-GAD in type 2 diabetes may be a LADA marker which specifically marks the group of patients with type 2 diabetes, in whom there is a faster metabolic death of beta cells. The current classification of diabetes is vague, and in the near future it should be modified based on specific patient characteristics, phenotypic appearance, as well as the results of additional tests. Determination of antibodies AMA, ASMA, APCA and anti-LKM does not seem to be significant in the diagnosis of diabetes and its chronic complications.

Authors and Affiliations

Joanna Litwińczuk-Hajduk, Małgorzata Bernat-Karpińska, Marek Kowrach, Paweł Piątkiewicz

Keywords

Related Articles

Metallothioneins and its role in metal regulation, binding of reactive oxygen species, apoptosis and cell differentiation

Metallothioneins (MT) are the widespread proteins in animal world. These proteins are characterized by the low invariability of their structure. The number of aminoacids is fixed in every animal group, that is 60 (or 61...

Large plexiform neurofibroma on right thigh of a farmer in the course of Recklinghausen disease – Case report

A 59-year-old farmer was admitted to the Department of Trauma Surgery because of pain associated with the presence of a tumour on the side of the right thigh. The patient stated that his biggest problem was great difficu...

Patient care after heart and kidney transplantation – case report

A patient after vascularized organ transplantation requires especially attentive medical care because of the risk of rejection of the transplant, the necessity for monitoring immunosuppressive therapy, and increased susc...

Motives for the choice of not undergoing breast reconstruction

[b]Introduction and objective.[/b] Currently, most women with less advanced breast cancer are offered operations with breast conserving treatment; however, if it is necessary to completely remove the breast, the patients...

Andersen-Tawil syndrome (ATS) – Case report and literature review

Andersen-Tawil Syndrome (ATS) is a rare genetic disorder inherited in an autosomal dominant pattern caused by mutations in the [i]KCNJ2[/i] gene encoding Kir2.1 protein forming potassium ion channel, leading to disruptio...

Download PDF file
  • EP ID EP79295
  • DOI 10.5604/18982395.1208185
  • Views 87
  • Downloads 0

How To Cite

Joanna Litwińczuk-Hajduk, Małgorzata Bernat-Karpińska, Marek Kowrach, Paweł Piątkiewicz (2016). Autoimmunity markers in subjects with diabetes. Journal of Pre-Clinical and Clinical Research, 10(1), 28-33. https://europub.co.uk/articles/-A-79295